← Leaderboards
Moumita Ghosh
National Jewish Health
$3,628,894
Attributed
$5,814,662
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $837.3K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,814,662 · 4
By mechanism
R01$5,570,354 · 3
K18$244,308 · 1
Top collaborators
- York E Miller6 shared
- Richard W Vandivier3 shared
Most similar at National Jewish Health
Same institution · by research overlap
- Susan M Majka$13,999,914
- Stijn Piet Johan De Langhe$10,419,756
- Hong W Chu$18,238,701
- Carl W White$29,966,481
- Patrick Scott Hume$703,262
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularSelf-RenewalStem CellsCell TypeResponseProgenitorSmoking CessationBiopsyFunctional DisorderEpitheliumSmokerMaintenancePublic Health RelevancePropertyCellsBaseIn VitroGene ExpressionHistologicDesignPreventTranscriptome SequencingRepairedEpithelial
Grant awards (14)
Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD$701,805
R01 · FY2025 · HL
Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD$694,181
R01 · FY2024 · HL
Airway Basal Progenitor Dysfunction in the Detection, Progression and Pathogenesis of Early COPD$704,544
R01 · FY2023 · HL
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$305,715
R01 · FY2022 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$502,882
R01 · FY2021 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$500,948
R01 · FY2020 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$90,858
R01 · FY2019 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$427,989
R01 · FY2018 · CA · contact PI
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution$442,614
R01 · FY2017 · CA · contact PI
Exhaustion of Airway Progenitor Cells Indicates Susceptibility to COPD$394,731
R01 · FY2017 · HL · contact PI
Exhaustion of Airway Progenitor Cells Indicates Susceptibility to COPD$394,731
R01 · FY2016 · HL · contact PI
Exhaustion of Airway Progenitor Cells Indicates Susceptibility to COPD$409,356
R01 · FY2015 · HL · contact PI
A Promitotic Stem Cell Niche: Role For Beta-Catenin and TGFbeta$122,154
K18 · FY2012 · HL · contact PI
A Promitotic Stem Cell Niche: Role For Beta-Catenin and TGFbeta$122,154
K18 · FY2011 · HL · contact PI